Insights ~2~ - MolDrug AI Systems

Newsletter #2 MolDrug

Insights

~2~

Welcome to the second newsletter of MolDrug!

At MolDrug AI Systems, we work at the intersection of computational science and molecular research, using in silico pipelines to support decision-making in the early-stages of drug discovery. By combining data-driven approaches with advanced modelling techniques, we help move from biological understanding to actionable molecular design.

From identifying relevant therapeutic targets and analysing biological pathways to designing and optimising candidate molecules or exploring biomarkers, our work helps make early-stage drug discovery more efficient and better informed.

Through this newsletter, we bring together our latest updates, from scientific publications and milestones to media visibility and participation in scientific and technical events. In “Did you know?”, we take a closer look at the science behind our work, and share what lies ahead.

Follow along to keep up with our latest updates

MolDrug will be a Golden Sponsor of the IV Foro Innovación Cosmética, organised by AINIA and Parque Científico de la UMH (PCUMH).

The event will bring together researchers, technological, institutes, CROs and stakeholders to discuss innovation, sustainability, and emerging trends in the cosmetics sector.

We look forward to seeing you there!

Our Senior Researcher, Laureano E. Carpio, has been appointed Secretary of the Early Career Scientists (ECS) committee of the Sociedad Española de Química Terapéutica (SEQT).

This new role reflects his involvement in the scientific community and his contribution to advancing medicinal chemistry and chemical biology.

Congratulations on this achievement!

Take a look at MolDrug AI Systems’ scientific publications (with link to directly access):

Our research publications

A look back at MolDrug’s events:

Transfiere, European Forum for Science, Technology and Innovation · Málaga
MolDrug took part in this European event connecting science, industry, and public administration. Our team member, Laureano E. Carpio, attended the forum, focused on translating knowledge into real impact.

AseBio Event: “The innovative biotechnology sector and its key role in strategic autonomy” · Madrid
MolDrug attended this event organised by AseBio, highlighting biotechnology as a strategic pillar for Europe’s future.

Our Business Development Manager, Simón Perera, took part in discussions on strengthening the biotech ecosystem.

Internal Session: Strengthening Internal Communication
MolDrug held an internal session led by our colleague, Laureano E. Carpio, focused on improving communication across the team and enhancing internal alignment.

Did you know that the human microbiome plays an important role in maintaining our health?

When the balance between microorganisms and the human body is disrupted, a condition known as dysbiosis, it can contribute to the development of different diseases.

To address this, strategies such as prebiotics, probiotics, and postbiotics are being explored, along with the development of therapeutic compounds designed to mimic microbiome–host interactions.

At MolDrug, we also contribute to this field through projects like COMPPI (DIN2024-013557), funded by MICIU/AEI/10.13039/501100011033 (AEI), which studies the interaction between gut microbiota proteins and the human immune system.

Don’t miss MolDrug’s upcoming events:

19 May: V Foro Colabora bioval

28 May: IV Foro Innovación Cosmética

To get in touch before the event, write to: info@moldrug.com

Thank you for staying connected with MolDrug.

Please share this newsletter with colleagues who may be interested.

Stay connected with MolDrug

Copyright © 2026 MolDrug AI Systems S.L, all rights reserved.

Our mailing address is:
MolDrug AI Systems S.L
Calle Nicolás Copérnico 6
Parque Tecnológico de Valencia
46980 Paterna (Valencia, Spain)

MolDrug AI Systems

Contact